Teva Pharmaceutical Industries has entered an agreement to acquire Gecko Health Innovations, Inc., a software and product solutions company that aids in compliance and adherence improvement in the management of respiratory diseases.

Teva gains CareTRx, a cloud-based solution designed to simplify chronic respiratory disease management, connecting patients and caregivers through remote monitoring and real-time adherence tools. Teva will explore innovative ways to apply the CareTRx technology to its pipeline and portfolio of respiratory products with the goal of enhancing clinical outcomes.

“Teva is committed to optimizing respiratory care through the development of new therapies and novel delivery systems to better serve patients living with respiratory conditions,” said Michael Hayden, M.D., Ph.D., president of Global R&D and chief scientific officer at Teva.

“During the last three years, we have designed and built a system to support respiratory disease management by intuitively connecting caregivers, patients, and families,” said Dr. Yechiel Engelhard, CEO and Founder of Gecko Health Innovations. “In founding Gecko Health Innovations, our vision was to connect chronic medication management into one platform, leveraging this information to support and empower patients by partnering with leading players in the healthcare and pharmaceutical industries. We are very excited to realize this vision as it aligns to Teva’s focus on innovative patient solutions.”